![]() The larger and more expensive Phase III trials designed to meet the onerous demands and standards of healthcare regulators are the real test of any speculative biotech research business. However, generally passing Phase II trial stage is the easy part as these trials are generally around proving safety, among other things. It has successfully completed two Phase II clinical trials for drugs to treat osteoarthritis and Ross River virus. One widely tipped candidate as a potential real deal biotech is Paradigm Biopharmaceuticals Ltd ( ASX: PAR). High costs and low revenues are not a good investing combination, but if you do buy a biotech business prior to it getting a blockbuster drug approved you could be onto some eye-watering 1,000%+ returns. ![]() The local biotech sector is fall of landmines able to blow up your capital at any time as most biotech businesses still at the clinical trial stage have no sales revenue and huge clinical trial research costs with no guarantee of ever commercialising a product. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |